Skip to main content
FinSpry Logo
FinSpry
AUTL logo
AUTL
(NASDAQ)
Autolus Therapeutics plc
$2.24-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Autolus Therapeutics (AUTL) Stock Price & Financial Analysis

Autolus Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.22 - $2.31
52-Week High$2.58
52-Week Low$1.18
Open$2.31
Volume1.82M
Average Volume (3M)2.79M
Market Cap596.16M
Shares Outstanding266.14M
Price to Sales (P/S)6.44
Price to Book (P/B)5.48
EV/EBITDA-2.21
Revenue (TTM)92.62M
Net Income (TTM)-288.96M
Free Cash Flow (TTM)-311.45M
EPS (TTM)$-1.09
Profit Margin-311.98%
Operating Margin-285.91%
Return on Equity (ROE)-265.53%
Debt to Equity0.73
50-Day MA$1.88
200-Day MA$1.63
52-Week Change53.42%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Autolus Therapeutics

What is the current stock price for AUTL?

As of the latest trading session, AUTL stock trades at $2.24. The 52-week range is $1.18–$2.58, with a day range of $2.22–$2.31.

What is the P/E ratio for AUTL?

The P/E ratio (Price-to-Earnings) for AUTL is shown in the Key Statistics section. This valuation metric helps compare Autolus Therapeutics plc to industry peers.

Does AUTL pay dividends?

Autolus Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AUTL?

Based on 3 analysts, the consensus for AUTL is Buy.

What is the market cap of AUTL?

Autolus Therapeutics's market capitalization is $596.2M, classifying it as a small-cap company. Autolus Therapeutics operates in the Healthcare sector within the Biotechnology industry.